cannabis abuse
Information
- Disease name
- cannabis abuse
- Disease ID
- DOID:9505
- Description
- "A substance abuse that involves the recurring use of cannabis despite negative consequences." [url:http\://en.wikipedia.org/wiki/Cannabis_%28drug%29]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT06249542 | Active, not recruiting | N/A | Implementing Screening for Cannabis and Other Drug Use Disorders in Primary Care: Impact on Diagnosis and Treatment | January 2015 | July 31, 2024 |
NCT00149643 | Completed | Phase 2 | Effectiveness of Fluoxetine in Young People for the Treatment of Major Depression and Marijuana Dependence | September 2004 | December 2012 |
NCT00350285 | Completed | Phase 2 | The Teen Marijuana Check-Up | September 2004 | June 2008 |
NCT00376233 | Completed | Niacin Flushing as Marker of Cannabis Effects on Arachidonic Acid Pathways in Schizophrenia | February 2004 | June 2005 | |
NCT00108407 | Completed | N/A | Study Comparing Two Types of Psychotherapy for Treating Depression and Substance Abuse | October 2004 | |
NCT00498550 | Completed | Phase 4 | Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual | October 2000 | March 2009 |
NCT01037608 | Completed | Phase 1 | Effects of Sativex(Registered Trademark) and Oral THC on Attention, Affect, Working Memory, Reversal Learning, Physiology and Brain Activation | May 8, 2007 | December 12, 2011 |
NCT01110434 | Completed | Phase 2 | Biobehavioral Effects of Topiramate on Cannabis-Related Outcomes in Adolescents | December 2009 | May 2012 |
NCT01204723 | Completed | Phase 1 | Medications Development for the Treatment of Cannabis Related Disorders | August 2009 | April 2012 |
NCT02319746 | Completed | N/A | COGNITIVE BEHAVIORAL THERAPY PROGRAM TO FIRST-EPISODE PSYCHOSIS PATIENTS AND CANNABIS ABUSE | September 2013 | September 2019 |
NCT01603992 | Completed | Quiting Marijuana Use: Self-report Study of Quitting Straegies and Withdrawal Symptoms | November 8, 2005 | May 3, 2012 | |
NCT01875796 | Completed | Phase 1 | Integrated CBT for Cannabis Dependence With Co-occurring Anxiety Disorders | June 2013 | |
NCT01639872 | Completed | Phase 4 | Clozapine for Cannabis Use in Schizophrenia | May 1, 2013 | March 29, 2017 |
NCT06395688 | Not yet recruiting | Phase 1 | Drug-Drug Interaction Between THC and AEF0117 | June 2024 | October 2024 |
NCT05219825 | Recruiting | N/A | Breathwork-assisted Treatment for Cannabis Use Disorder | February 6, 2022 | August 2024 |
NCT05833230 | Recruiting | N/A | Investigating Real-world Stress-related Mechanisms in Heavy Cannabis Users | June 1, 2023 | January 30, 2025 |
NCT01439828 | Terminated | Phase 2 | Clinical Trial of N-acetylcysteine Versus Placebo Efficacy in the Cannabis Withdrawal | February 2012 | February 2015 |
NCT00687609 | Terminated | Phase 4 | Pilot Evaluation of Atomoxetine on Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Adolescents With Cannabis abusE | September 2008 | June 2009 |
NCT00484367 | Unknown status | Phase 2/Phase 3 | A Comparison of Adolescent Group Therapy and Transitional Family Therapy for Adolescent Alcohol and Drug Abusers | July 1999 | August 2012 |
NCT01784627 | Withdrawn | Phase 1 | Trial of Computerized SBI to Reduce Teen Alcohol Use | January 2015 | October 2017 |
- Disase is a (Disease Ontology)
- DOID:302
- Cross Reference ID (Disease Ontology)
- ICD10CM:F12
- Cross Reference ID (Disease Ontology)
- ICD10CM:F12.1
- Cross Reference ID (Disease Ontology)
- ICD9CM:305.2
- Cross Reference ID (Disease Ontology)
- MESH:D002189
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:268769003
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:37344009
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0006868
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0024809
- Exact Synonym (Disease Ontology)
- marijuana abuse